{"body":"<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>national focus register<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Centralized database of all foci of malaria infection in a country, which includes relevant data on physical geography, parasites, hosts and vectors for each focus<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>national malaria case register<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Centralized database with individual records of all malaria cases registered in a country<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>net, insecticide-treated (ITN)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Mosquito net that repels, disables or kills mosquitoes that come into contact with the insecticide on the netting material. The three categories of insecticide-treated net are:<\/p>&#13;\n&#13;\n<ul><li>conventionally treated net: a mosquito net that has been treated by dipping it into a WHO-recommended insecticide. To ensure its continued insecticidal effect, the net should be re-treated periodically.<\/li>&#13;\n\t<li>long-lasting insecticidal net: a factory-treated mosquito net made of netting material with insecticide incorporated within or bound around the fibres. The net must retain its effective biological activity for at least 20 WHO standard washes under laboratory conditions and three years of recommended use under field conditions.<\/li>&#13;\n\t<li>pyrethroid-PBO net: a mosquito net that includes both a pyrethroid insecticide and the synergist piperonyl butoxide. To date, pyrethroid-PBO nets have not met required thresholds to qualify as long-lasting insecticidal nets.<\/li>&#13;\n<\/ul><\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>oocyst<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The stage of malaria parasite that develops from the ookinete; the oocyst grows on the outer wall of the midgut of the female mosquito.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>oocyst rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Percentage of female <em>Anopheles<\/em> mosquitoes with oocysts on the midgut<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>ookinete<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Motile stage of malaria parasite after fertilization of macrogamete and preceding oocyst formation<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>parasitaemia<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Presence of parasites in the blood<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>parasitaemia, asymptomatic<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The presence of asexual parasites in the blood without symptoms of illness<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>parasite clearance time<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Time between first drug administration and the first examination in which no parasites are present in the blood by microscopy<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>parasite density<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Number of asexual parasites per unit volume of blood or per number of red blood cells<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>parasite density, low<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Presence of <em>Plasmodium <\/em>parasites in the blood at parasite density below 100 parasites\/\u03bcl<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>patent period<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Period during which malaria parasitaemia is detectable<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong><em>Plasmodium<\/em><\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Genus of protozoan blood parasites of vertebrates that includes the causal agents of malaria. <em>P. falciparum<\/em>, <em>P. malariae<\/em>, <em>P. ovale<\/em> and <em>P. vivax<\/em> cause malaria in humans. Human infection with the monkey malaria parasite <em>P. knowlesi <\/em>and very occasionally with other simian malaria species may occur in tropical forest areas.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>population at risk<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Population living in a geographical area where locally acquired malaria cases have occurred in the past three years<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>population, target<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">An implementation unit targeted for activities or services (e.g., prevention, treatment)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>pre-erythrocytic development<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Development of the malaria parasite from the time it first enters the host and invades liver cells until the hepatic schizont ruptures<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>pre-patent period<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Period between inoculation of parasites and the first appearance of parasitaemia<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>prequalification<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Process to ensure that health products are safe, appropriate and meet stringent quality standards for international procurement<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>preventive chemotherapy<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Use of medicines either alone or in combination to prevent malaria infections and their consequences<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>prophylaxis<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Any method of protection from or prevention of disease; when applied to chemotherapy, it is commonly termed \u201cchemoprophylaxis\u201d.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>prophylaxis, causal<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Complete prevention of erythrocytic infection by destroying the pre-erythrocytic forms of the parasite<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>public health value*<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A product has public health value if it has proven protective efficacy to reduce or prevent infection and\/or disease in humans, at the individual level, community level or both<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>rapid diagnostic test (RDT)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Immunochromatographic lateral flow device for rapid detection of malaria parasite antigens<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>rapid diagnostic test, combination<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Malaria rapid diagnostic test that can detect a number of different malaria species<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>rapid diagnostic test positivity rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Proportion of positive results among all rapid diagnostic tests performed<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>reactive focal screening, testing, treating or drug administration<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Screening, testing, treating or administering drugs to a subset of a population in a given area in response to the detection of an infected person<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>recrudescence<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Recurrence of asexual parasitaemia of the same genotype(s) that caused the original illness, due to incomplete clearance of asexual parasites after antimalarial treatment<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>recurrence<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Reappearance of asexual parasitaemia after treatment, due to recrudescence, relapse (in <em>P. vivax<\/em> and <em>P. ovale<\/em> infections only) or a new infection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>reinfection<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A new infection that follows a primary infection; can be distinguished from recrudescence by the parasite genotype, which is often (but not always) different from that which caused the initial infection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>reintroduction risk<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The risk that endemic malaria will be re-established in a specific area after its elimination<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>relapse<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Recurrence of asexual parasitaemia in <em>P. vivax<\/em> or <em>P. ovale<\/em> infections arising from hypnozoites<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>repellent<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Any substance that causes avoidance in mosquitoes, especially substances that deter them from settling on the skin of the host (topical repellent) or entering an area or room (area repellent, spatial repellent, excito-repellent)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>resistance<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">(See Drug resistance, Insecticide resistance)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>ring form (ring stage, ring-stage trophozoite)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Young, usually ring-shaped malaria trophozoites, before pigment is evident by microscopy<\/p>&#13;\n<\/div>&#13;\n","title":"Glossary: N - R","nid":776,"vid":4341,"created":1627908279,"changed":1627908302,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_left_right_navigation":1,"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_recommendations":1,"recommendation":"<p>All cases of suspected malaria should have a parasitological test (microscopy or Rapid diagnostic test (RDT)) to confirm the diagnosis.<br \/>\r\nBoth microscopy and RDTs should be supported by a quality assurance programme.<br \/>\r\n<font color=\"#4090CF\"><em>Good practice statement<\/em><\/font><\/p>\r\n","recommendation_title":"Rapid diagnostic test (RDT)","field_references":null}